Services

Growth Factors

Advanced Biological Therapies in Sport Horses

Modern Scientific Approach to Joint Health and Athletic Performance

In contemporary veterinary medicine for the sport horse, particularly in show jumping horses, autologous biological and cellular therapies represent a fundamental shift in the management of joint inflammation, cartilage degeneration, and high-performance-related injuries.

Unlike purely symptomatic treatments, these approaches use advanced biological mechanisms — many derived from the horse’s own body — to:

  • modulate inflammation
  • protect articular structures
  • optimize long-term athletic prognosis

What Are Orthobiologic and Cellular Therapies?

Therapies such as IRAP, PRP and Alpha-2-Macroglobulin (A2M) belong to the group of:

Autologous Orthobiologic Therapies

These treatments are derived from the horse’s own blood and are designed to intervene in key biological processes involved in:

  • joint inflammation
  • cartilage degradation
  • tissue repair capacity

At a more advanced level, cellular therapies expand the concept of traditional orthobiology toward deeper biological modulation.

IRAP (ACS) – Targeted Modulation of Joint Inflammation

IRAP, also known as Autologous Conditioned Serum (ACS), focuses on inhibiting Interleukin-1 (IL-1), a central cytokine in inflammatory and degenerative joint processes.

Clinical Indications

  • Early or moderate osteoarthritis
  • Recurrent synovitis
  • High-load joints in show jumping horses

Clinical Approach

IRAP does not regenerate tissue. Its goal is to reduce the intra-articular inflammatory cascade, promoting a more stable biological environment for performance.

PRP – Biological Stimulation of Tissue Repair

Platelet-Rich Plasma (PRP) is an autologous platelet concentrate rich in growth factors involved in tissue repair and remodeling.

Clinical Indications

  • Tendon injuries
  • Ligament injuries
  • Muscle lesions
  • Selected joint cases

Clinical Approach

PRP is indicated when the objective is to stimulate biological repair, particularly in soft tissues exposed to high mechanical stress.

Alpha-2-Macroglobulin (A2M) – Active Cartilage Protection

Alpha-2-Macroglobulin (A2M) is a protein capable of inhibiting enzymes responsible for cartilage degradation.

Clinical Indications

  • Early-stage osteoarthritis
  • Young high-value sport horses
  • Preventive joint strategies

Clinical Approach

A2M plays a protective and preventive role, especially when the objective is to preserve cartilage integrity before irreversible damage occurs.


APS – Combined Biological Solution

Autologous Protein Solution (APS) combines:

  • anti-inflammatory proteins
  • growth factors
  • cellular components with immunomodulatory effects

Clinical Approach

APS is indicated in joints with active inflammation where broader biological modulation is required.


Exosomes and Cellular Therapies – The Emerging Frontier

Exosome-based and cellular therapies are currently in an emerging phase but generate strong interest in both human and veterinary medicine.

These approaches act through highly specific cellular signaling mechanisms, with potential to modulate inflammation, tissue repair and intercellular communication more precisely than conventional therapies.

Current Clinical Perspective

These options represent the future of regenerative medicine and must be indicated with clinical judgment, experience, and deep understanding of performance demands — particularly in high-level show jumping horses.


Which Therapy Is Most Appropriate?

There is no universal solution. Treatment selection must be based on:

  • type of lesion
  • stage of disease
  • age of the horse
  • short- and long-term performance goals
Clinical SituationRecommended Approach
Predominant joint inflammationIRAP (ACS)
Soft tissue injuryPRP
Cartilage protectionA2M
Complex inflammationAPS
Selected advanced casesCellular / Exosomal therapies

Application in Show Jumping and High-Performance Horses

In show jumping horses, where joints are subjected to repeated and high mechanical loads, the objective is not merely symptom control, but protection of long-term athletic longevity.

The correct indication of biological and cellular therapies forms part of an advanced veterinary strategy based on precise diagnosis, performance experience, and transparent communication with owners and buyers.


Individualized Clinical Strategy

The indication of biological therapies requires accurate diagnosis, high-performance clinical experience, and long-term performance vision.

At Sporthorses.vet, these therapies are integrated into a global veterinary strategy focused on athletic longevity and performance preservation

SportHorses.vet is an independent equine veterinary service based in Bocholt (3950), Belgium.

Specialized in equine orthopedics, sport horse medicine and performance-oriented veterinary care across Europe.